BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2889474)

  • 1. Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
    Page JD; Chaney SG; Hall IH; Lee KH; Holbrook DJ
    Biochim Biophys Acta; 1987 Nov; 926(2):186-94. PubMed ID: 2889474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.
    Hall IH; Williams WL; Grippo AA; Lee KH; Holbrook DJ; Chaney SG
    Anticancer Res; 1988; 8(1):33-42. PubMed ID: 2895992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
    Hedstrom L; Wang CC
    Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
    Yamada Y; Natsumeda Y; Weber G
    Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells.
    Hodges SD; Fung E; McKay DJ; Renaux BS; Snyder FF
    J Biol Chem; 1989 Oct; 264(30):18137-41. PubMed ID: 2572589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of inosinic acid dehydrogenase by 8-substituted purine nucleotides.
    Skibo EB; Meyer RB
    J Med Chem; 1981 Oct; 24(10):1155-61. PubMed ID: 6120232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y; Goto H; Yoshino M; Ogasawara N
    Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
    Hedstrom L; Cheung KS; Wang CC
    Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active-site modification of native and mutant forms of inosine 5'-monophosphate dehydrogenase from Escherichia coli K12.
    Gilbert HJ; Drabble WT
    Biochem J; 1980 Nov; 191(2):533-41. PubMed ID: 6112982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of inosinic acid dehydrogenase. 2-Substituted inosinic acids.
    Wong CG; Meyer RB
    J Med Chem; 1984 Apr; 27(4):429-32. PubMed ID: 6142953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo.
    Williams WL; Hall IH; Grippo AA; Oswald CB; Lee KH; Holbrook DJ; Chaney SG
    J Pharm Sci; 1988 Feb; 77(2):178-84. PubMed ID: 2896234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification, characterization, and kinetic analysis of inosine 5'-monophosphate dehydrogenase of Tritrichomonas foetus.
    Verham R; Meek TD; Hedstrom L; Wang CC
    Mol Biochem Parasitol; 1987 May; 24(1):1-12. PubMed ID: 2886911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP dehydrogenase from the intracellular parasitic protozoan Eimeria tenella and its inhibition by mycophenolic acid.
    Hupe DJ; Azzolina BA; Behrens ND
    J Biol Chem; 1986 Jun; 261(18):8363-9. PubMed ID: 2873141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human IMP dehydrogenase catalyzes the dehalogenation of 2-fluoro- and 2-chloroinosine 5'-monophosphate in the absence of NAD.
    Antonino LC; Wu JC
    Biochemistry; 1994 Feb; 33(7):1753-9. PubMed ID: 7906542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct target sites on IMP dehydrogenase in chemotherapy.
    Yamada Y; Natsumeda Y; Yamaji Y; Weber G
    Adv Exp Med Biol; 1989; 253B():57-63. PubMed ID: 2575352
    [No Abstract]   [Full Text] [Related]  

  • 18. Affinity chromatography on immobilised nucleotides. The synthesis, specificity and applications of immobilised inosine 5'-monophosphate.
    Clonis YD; Lowe CR
    Eur J Biochem; 1980 Sep; 110(1):279-88. PubMed ID: 6108211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of inosinate dehydrogenase.
    Kuttan R; Saunders P
    Biochem Int; 1987 Feb; 14(2):211-8. PubMed ID: 2883976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.